Ibadulla Mirzayev1,2, Ahmet Kaan Gündüz3,4, Aylin Okçu Heper5. 1. Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey. 2. Department of Ophthalmology, Dünya Göz Hospital, Ankara, Turkey. 3. Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey. drkaangunduz@gmail.com. 4. Private Office, Farilya Business Center 8/38, Çukurambar, Ankara, Turkey. drkaangunduz@gmail.com. 5. Departmant of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey.
Abstract
OBJECTIVES: To investigate the results of partial lamellar sclerouvectomy (PLSU) for anteriorly located uveal tumours. METHODS: We reviewed the tumour features, histopathologic findings, complications, visual acuity outcomes, eye preservation, metastasis, and mortality data of 56 cases with uveal tumours who underwent PLSU between February 1999 and February 2019. RESULTS: The mean largest tumour base diameters were 5.8 × 3.4 mm and the mean tumour thickness was 3.3 mm. Histopathologically, 30 (53.6%) eyes had malignant melanoma, 13 (23.2%) had nevus, 5 (8.9%) had iris stromal cyst, 4 (7.1%) had melanocytoma, 2 (3.6%) had Fuchs' adenoma, 1 (1.8%) had iris pigment epithelial cyst, and 1 (1.8%) had invasive breast cancer metastasis. The most common postoperative complications included cataract in 21 (37.5%) eyes, vitreous haemorrhage in 15 (26.8%), scleral thinning in 10 (17.9%), and hyphema in 6 (10.7%). At a mean follow-up of 40.4 (range: 10-201) months, tumour recurrence was observed in 2/30 (6.7%) eyes with melanoma and 1/5 (20.0%) eye with iris stromal cyst. Eyes with recurrent melanoma were treated with enucleation. Liver metastasis developed in only 1 (3.3%) melanoma case. All patients were alive at the end of follow-up. CONCLUSIONS: PLSU is a successful treatment method for many anteriorly located uveal tumours. In our series, the overall tumour recurrence and globe salvage rates were 5.4% and 96.4% respectively. Among melanoma cases, the metastasis rate was 3.3% and survival rate was 100%.
OBJECTIVES: To investigate the results of partial lamellar sclerouvectomy (PLSU) for anteriorly located uveal tumours. METHODS: We reviewed the tumour features, histopathologic findings, complications, visual acuity outcomes, eye preservation, metastasis, and mortality data of 56 cases with uveal tumours who underwent PLSU between February 1999 and February 2019. RESULTS: The mean largest tumour base diameters were 5.8 × 3.4 mm and the mean tumour thickness was 3.3 mm. Histopathologically, 30 (53.6%) eyes had malignant melanoma, 13 (23.2%) had nevus, 5 (8.9%) had iris stromal cyst, 4 (7.1%) had melanocytoma, 2 (3.6%) had Fuchs' adenoma, 1 (1.8%) had iris pigment epithelial cyst, and 1 (1.8%) had invasive breast cancer metastasis. The most common postoperative complications included cataract in 21 (37.5%) eyes, vitreous haemorrhage in 15 (26.8%), scleral thinning in 10 (17.9%), and hyphema in 6 (10.7%). At a mean follow-up of 40.4 (range: 10-201) months, tumour recurrence was observed in 2/30 (6.7%) eyes with melanoma and 1/5 (20.0%) eye with iris stromal cyst. Eyes with recurrent melanoma were treated with enucleation. Liver metastasis developed in only 1 (3.3%) melanoma case. All patients were alive at the end of follow-up. CONCLUSIONS: PLSU is a successful treatment method for many anteriorly located uveal tumours. In our series, the overall tumour recurrence and globe salvage rates were 5.4% and 96.4% respectively. Among melanoma cases, the metastasis rate was 3.3% and survival rate was 100%.
Authors: Swathi Kaliki; Carol L Shields; Ralph C Eagle; Geeta K Vemuganti; Ana Almeida; Fairooz P Manjandavida; Kaustubh Mulay; Santosh G Honavar; Jerry A Shields Journal: Ophthalmology Date: 2013-06-21 Impact factor: 12.079
Authors: Gregor D Willerding; Dino Cordini; Lutz Moser; Lothar Krause; Michael H Foerster; Nikolaos E Bechrakis Journal: Br J Ophthalmol Date: 2015-07-29 Impact factor: 4.638
Authors: Melis Palamar; Carol L Shields; Brian P Marr; Ralph C Eagle; Jerry A Shields Journal: Eur J Ophthalmol Date: 2009 May-Jun Impact factor: 2.597
Authors: Ido Didi Fabian; Caroline Thaung; Lamis AlHarby; Karen Sisley; Hardeep S Mudhar; Rachel E Doherty; Andrew W Stacey; Amit K Arora; Victoria M L Cohen; Mandeep S Sagoo Journal: Am J Ophthalmol Date: 2017-07-01 Impact factor: 5.258
Authors: Mihai Adrian Păsărică; Paul Filip Curcă; Christiana Diana Maria Dragosloveanu; Cătălina Ioana Tătaru; Ioana Roxana Manole; Gabriela Elisabeta Murgoi; Alexandru Călin Grigorescu Journal: Diagnostics (Basel) Date: 2022-05-25
Authors: Isabel Relimpio-López; Antonio Manuel Garrido-Hermosilla; Francisco Espejo; María Gessa-Sorroche; Lourdes Coca; Belen Domínguez; María Jesús Díaz-Granda; Beatriz Ponte; María José Cano; Enrique Rodríguez de la Rúa; Francisco Carrasco-Peña; Carlos Míguez; Jonathan Saavedra; Antonio Ontanilla; Carlos Caparrós-Escudero; Juan José Ríos; José Antonio Terrón Journal: J Clin Med Date: 2022-03-15 Impact factor: 4.241